Summary.-The use of perchloric acid and water for the extraction of CEA from tumour and foetal tissues has been investigated. In 
THE preliminary extraction of carcinoembryonic antigen (CEA) with 1 OM perchloric acid from liver metastases of colonic tumours was described by Krupey et al. (1972) and this method, with minor modifications, has been largely adopted by other workers as the initial stage in the isolation of CEA for radioimmunoassay. Exclusion chromatography on Sepharose 4B and Sephadex G-200 (Coligan et al., 1972; Krupey et al., 1972) and concanavalin A affinity chromatography (Brattain et al., 1975; Rogers, Searle and Bagshawe, 1976) have been used to purify the product. CEA is a macromolecular glycoprotein which has been shown to exhibit heterogeneity in its electrophoretic mobility (Darcy, Turberville and James, 1973; Rogers, Searle and Wass, 1975; Goleski-Reilly, 1 973a, b), isoelectric point * To whom enquiries should be made. (Coligan et al., 1973) , molecular size (Coligan et al., 1972) and in its ability to bind to the lectin concanavalin A (Slayter and Coligan, 1976) .
Despite the widespread use of perchloric acid for the isolation of CEA, studies on the possible effect of the acid on the carbohydratestructureandheterogeneityof CEA have not been widely reported. However, a comparison of the use of whole plasma and perchloric-acid-extracted plasma for CEA radioimmunoassay has recently appeared (Ashman, Ludbrook and Marshall, 1977) . The present investigation provides new comparative data on the fractionation of aqueous and perchloric acid extracts of CEA from tumour tissue, foetal colon and serum, and is a further study in which the chemistry and possible cancer-specificity of various forms of CEA are examined.
MATERIALS AND METHODS

Tissues
The primary colon tumours were obtained surgically and processed immediately. All metastatic tumour and normal colon tissues were necropsy specimens obtained within 24 h of death and generally stored at -20°C until used. The foetal colons were obtained from 26 foetuses aged 15-20 weeks collected over a period of 6 weeks.
Extraction procedure for tumour and normal tissue
The scheme for extracting CEA from rectal, colonic and bronchial tumour tissue and also normal colon is given in Fig. 1 . The tumour (100-1500 g) was dissected from surrounding normal tissue, minced and macerated in a Townsen and Mercer top-drive macerator for 10 min in an equal volume of chilled water. The homogenate was divided into two equal portions: I and II (Fig. 1 ). Normal colon tissue was dissected from fat, briefly washed with water and cut into small pieces before mincing and macerating.
Route I.-The aqueous homogenate was centrifuged (30,000 g) for I h and the aqueous extract and residue separated. An equal volume of cold perchloric acid (2M) was added to an aliquot of the aqueous extract which was stirred for 5 min and recentrifuged (30,000 g). The supernatant was dialysed against tap water for 3 days and then against distilled water, and concentrated by ultrafiltration (Amicon PM 10) to 100-500 ml. The supernatant was designated Extract A. The residues obtained from each centrifugation step were stirred overnight at 4°C with 3M KCI (,200 ml/kg of original tissue), centrifuged and the supernatant dialysed against tap water and distilled water and concentrated. These CEA extracts were designated A-1 and A-2 respectively (see Fig. 1 ). The CEA recovered in each extract wvas estimated by routine radioimmunoassay. Route II.-The other half of the aqueous homogenate was treated directly with an equal volume of 2M perchloric acid. After stirring for 5 min the mixture was centrifuged (30,000 g) for -h. The supernatant designated B was dialysed and concentrated by ultrafiltration. The residue was treated with 3M KCI as described above and centrifuged and the supernatant, designated B-1, was dialysed and concentrated. The CEA content of each extract was estimated.
Gel filtration of crude extracts of Specimen 4
Aliquots of the crude extracts A, A-1, B and B-1 containing 76, 1204, 126 and 104 mg of protein and 7-1, 1-4, 6-8 and 2-7 mg of CEA respectively were applied to a column of Sepharose 6B (Pharmacia) (76 x 5 cm) previously equilibrated with sodium phosphate buffer (01M, pH 4.5). The column was eluted with the same buffer, at 43 ml/h and the fractions (6-5 ml) monitored by their absorbance at 280 mm and also assayed for CEA (Fig. 2) This was carried out using a column (29 x 10 cm) of concanavalin A-Sepharose (Pharmacia) as previously described (Rogers et al., 1974; Slayter and Coligan, 1976) . Briefly, this involved elution of fraction 1 with 0-1M sodium acetate buffer, pH 6, containing IM NaCl, 10-3M CaC12, 10-3M with the various buffers as described above and the CEA recovered in each fraction determined (Table IV) .
Extraction of foetal colon tissue
Twenty-six foetal colons (45 g) were briefly washed in water and cut into small pieces.
The tissue was then homogenized in 100 ml of water for 10 min at 4°C, using an MSE topdrive homogenizer fitted with an ice jacket. The homogenate was centrifuged at 76,000 g for 1 h and the aqueous extract and residue separated. The residue was treated by grinding with 50 ml of 3M KCI solution in a mortar. After stirring overnight the mixture was centrifuged and the KCI extract dialysed against tap water and distilled water and concentrated to 32 ml by Amicon (PM 10) ultrafiltration. This extract was designated A-I (see Fig. 1 and Table V) . Half of the aqueous extract (60 ml) was dialysed against several changes of distilled water and concentrated to 35 ml; this was designated the aqueous extract (Table V) . The other half of the aqueous extract was mixed with an equal volume of 2M perchloric acid, stirred for 5 min and centrifuged at 76,000 g for 1 h. The supernatant was dialysed against run- 
RESULTS AND DISCUSSION
Perchloric acid has been used extensively for the routine extraction of CEA from tumour tissues and for the pretreatment of plasma for indirect radioimmunoassay. However, it has been shown that perchloric acid can modify CEA (Rule and GoleskiReilly, 1 973a; Carrico and lJsategui-Gomez, 1975) . It is conceivable that perchloric acid could cleave sialic acid residues in CEA and modify other parts of the carbohydrate structure leading to changes in its properties.
Earlier unpublished studies from our laboratory and studies reported by Carrico and Usategui-Gomez (1975) had demonstrated that the yield of CEA obtained from colonic tumour tissue and measured by radioimmunoassay was considerably diminished by the perchloric acid treatment, and this appears to be the case with serum CEA also (Khoo, Hunt and Mackay, 1973a; Khoo and Mackay, 1973; Ashman et al., 1977) . It has been demonstrated further that CEA could be extracted from perchloric acid precipitates of tumour tissue by stirring overnight with 3M KCI solution (Rogers, 1976) or HCI at pH 3 0 (Dyce and Haverback, 1972 To explore the above effects more fully we have used various extraction procedures as illustrated in Fig. 1 . The recoveries of CEA in the various extracts obtained from colonic, rectal and bronchial tumours are presented in Table I . About twice as much CEA can be recovered in saline extracts as from the conventional perchloric-acid extract B, thus confirming our previous observations. However, when the tissue homogenate was centrifuged and perchloric acid added to the supernatant (Extract A) the recovery of CEA was better than that in Extract B, in all but one case. In this the CEA content of the tumour was unusually high (64 pLg/g). It appears from these experiments that perchloric-acid modifies some of the CEA in such a way that it binds to the insoluble part of the tissue homogenate.
The amount of CEA in perchloric acid extracts of the tumours (Table I) Coligan et al. (1972) .
The detection of CEA in the KCItreated perchloric-acid precipitate B-1 (Table I) (Dyce and Haverback, 1972) , and in this case no CEA was detected in the supernatant by immunodiffusion. The presence of comparatively large amounts of CEA in perchloric-acid precipitates raises questions about the use of perchloric acid for the routine preparation of CEA. The original CEA (Gold and Freedman, 1965) was extracted using phosphate-buffered saline, but more recent methods employ either perchloric-acid extraction directly on tumour homogenates (Coligan et al., 1972; Krupey et al., 1972) or after an initial centrifugation step (Plow and Edgington, 1975) . It is therefore important to establish whether the bound CEA differs chemically from nonbinding CEA or whether the effect of perchloric acid merely diminishes the yield.
Initial experiments using double diffusion have shown that CEA could also be extracted by treating the aqueous precipitate A-1 with 3M KCI solution, indicating that some molecules with CEA activity are bound to the insoluble tissue debris in the absence of perchloric acid. This has been confirmed by radioimmunoassay (Table II) . Isoelectric focusing studies have shown that perchloric acid denatures or precipitates predominantly CEA molecules with isoelectric points in the range 5-9 (Rule and Goleski-Reilly, 1973). These molecules possess fewer sialic acid residues than those which focus at lower pH value (Coligan et al., 1973 (Khoo et al., 1973; Ashman et al., 1977) . Table II compares the distribution of CEA in the perchloric-acid extract and precipitate for several pools of sera from patients with cancer. Seven out of 10 experiments showed the presence of CEA in the perchloric acid precipitate although, in contrast to tumour tissue, the amount was smaller than that in the supernatant.
Our results differ from those of Sorokin, Kupchik and Zamcheck (1973) which failed to show the presence of CEA activity in serum precipitates. This discrepancy may be due to the fact that these workers used individual serum samples containing smaller amounts of CEA than our pools of sera.
The smaller amount of CEA obtained from perchloric-acid precipitates of serum than from perchloric acid precipitates of colonic tumours may be due to prior removal of CEA, probably in an asialylated form, from the circulation by the liver. If this is so, any differences in cancer specificity between perchloric-acid-soluble CEA and precipitate CEA would not be expected to show up in a comparison of the direct and indirect assays. The lower assay value obtained with the indirect assay would then more probably be due to irreversible precipitation of CEA, which takes place on treatment with perchloric acid (Carrico and Usategui-Gomez, 1975) . The recent comparative study by Ashman et al. (1977) between a perchloric-acid extracted ammonium-sulphate precipitation assay and a whole-plasma doubleantibody assay is consistent with the above concept. The study failed to show any difference in cancer discriminatory ability between the two assay systems. band on Sepharose 6B (Fig. 2) . The elution profiles on Sephadex G-200, however, were not identical. Although a major peak ofCEA activity was shown for each extract, the elution volumes varied, corresponding to differences in molecular size (Fig. 3) (Fig. 4) Krupey et al. (1972) was fractionated on Sephadex G-200 into 2 peaks with CEA activity, although the bulk of the activity was present in the lower-mol. wt fraction. Coligan et al. (1972) on the other hand showed that the type of CEA elution profile on Sephadex G-200 depended on the tumour. Although a single peak of CEA activity with a sedimentation constant of 6-8 S was more typical, some tumours produced CEA which chromatographed with a double peak showing that a 178 -9I 3-6 large proportion of the CEA had a higher mol. wt. The extent to which heterogeneity in molecular size in CEA is an artefact resulting from the extraction procedure is unknown, although in this context it is interesting to note that CEA with a molecular size of 370,000 daltons has been detected in both perchloric-acidextracted serum and in whole serum from patients with cancer (Pletsch and Goldenberg, 1974 (I972) . The large amount of CEA lost at the Sepharose stage is difficult to account for, but this must be to some extent due to spreading of the CEA band on the column and to selection of the prominent CEA peak for further purification.
The results of concanavalin A-affinity chromatography of the partially purified extracts of CEA, obtained by Sepharose and Sephadex chromatography, are presented in Table IV . Five fractions were collected as described earlier, with most of the CEA appearing in fractions 2B, 3 and 4, and very small recoveries in the unbound peak and Peak 2A. This is in agreement with our previous studies (Rogers et al., 1976) and also those of Pritchard and Todd (1976) who found the unbound material to contain predominantly non-CEA mucopolysaccharides. In the present work we have eluted tightly bound material from the column after soaking overnight in 20% methyl glucoside, as suggested by Slayter and Coligan (1976) , thereby improving our total recoveries of CEA.
The recoveries of CEA in the Con A peaks of Extract B and the corresponding extract obtained from the precipitate B-1, are almost identical (Table IV) (Rogers, 1976) , it may be inferred that differences in soluble CEA and CEA from perchloric-acid precipitates may be restricted to carbohydrate residues on the periphery of CEA. Our result, although providing only indirect evidence, appears to be compatible with the possible role sialic acid might play in the susceptibility of CEA to precipitation in the presence of perchloric acid. The different elution patterns on Con A obtained with Extracts A and A-I, compared to those obtained with the Extracts B and B-1 just described, may be correlated with the differences in molecular size described earlier, but they are difficult to interpret in detail. It may be concluded, however, that the differences result from an overall effect of the different extraction procedures on the chemical structure of the carbohydrate chains in CEA. It appears that, to some extent, heterogeneity of CEA, as demonstrated by Con A affinity chromatography, is dependent on chemical changes in the carbohydrate caused by the action of perchloric acid. Whether carbohydrate heterogeneity is also due to aggregation of CEA or binding to other glycoproteins is unknown.
The recoveries of CEA in the Con A fractions obtained from the aqueous extract of Specimen 4 (Table IV) show similarities with the extracts discussed above. However, by treating the Con A fraction 2B obtained from the aqueous extract, with perchloric acid, its Con A binding is altered (Table IV) Carrico and Usategui-Gomez (1975) .
The second antigen may be similar to our previously described B-antigen which was also detected in purified CEA preparations after Con A fractionation, and by using conventional anti-CEA antisera (Rogers et al., 1974 (Rogers et al., , 1975 The implications of the present study on our recently published work (Rogers et al., 1977) on the disease specificity of Con A fractions of perchloric-acid-treated serum CEA, are difficult to ascertain until the chemical effects of perchloric acid on serum CEA have been established. Nevertheless our initial work suggested that heterogeneity of the carbohydrate appears to give rise to CEA molecules which vary in specificity for local and metastatic cancer, and that this specificity appeared not to be impaired by the action of perchloric acid.
Extraction of CEA from foetal colon The recoveries of CEA in the crude extracts A, A-1 and A-2 of foetal colon are shown in Table V (Rogers et al., 1977) .
Comparison between the recoveries for the Con A fractions of aqueous and perchloricacid-treated foetal CEA also show that part of the CEA in the unbound fraction and Fraction 3, on treatment with perchloric acid, is either denatured or irreversibly bound to the Con A-Sepharose. Undoubtedly, further work is required to substantiate these results, but the striking differences described in these preliminary experiments between colorectal CEA and foetal CEA are interesting and may suggest important differences in the structure of the carbohydrate chains.
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